Covid-19 Impact on Anti-Infective Vaccines Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Anti-Infective Vaccines Industry

1.7 COVID-19 Impact: Anti-Infective Vaccines Market Trends

2 Global Anti-Infective Vaccines Quarterly Market Size Analysis

2.1 Anti-Infective Vaccines Business Impact Assessment - COVID-19

2.1.1 Global Anti-Infective Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Anti-Infective Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Anti-Infective Vaccines Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Anti-Infective Vaccines Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Anti-Infective Vaccines Factory Price by Manufacturers

3.3 Location of Key Manufacturers Anti-Infective Vaccines Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Anti-Infective Vaccines Market

3.5 Key Manufacturers Anti-Infective Vaccines Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Anti-Infective Vaccines Segments, By Type

4.1 Introduction

1.4.1 Inactivated vaccines

1.4.2 Conjugate vaccines

1.4.3 Live/attenuated vaccines

4.2 By Type, Global Anti-Infective Vaccines Market Size, 2019-2021

4.2.1 By Type, Global Anti-Infective Vaccines Market Size by Type, 2020-2021

4.2.2 By Type, Global Anti-Infective Vaccines Price, 2020-2021

5 Impact of Covid-19 on Anti-Infective Vaccines Segments, By Application

5.1 Overview

5.5.1 Bacterial diseases

5.5.2 Viral diseases

5.2 By Application, Global Anti-Infective Vaccines Market Size, 2019-2021

5.2.1 By Application, Global Anti-Infective Vaccines Market Size by Application, 2019-2021

5.2.2 By Application, Global Anti-Infective Vaccines Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Emergent BioDefense Operations Lansing Inc.

7.1.1 Emergent BioDefense Operations Lansing Inc. Business Overview

7.1.2 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Introduction

7.1.4 Emergent BioDefense Operations Lansing Inc. Response to COVID-19 and Related Developments

7.2 Sanofi Pasteur

7.2.1 Sanofi Pasteur Business Overview

7.2.2 Sanofi Pasteur Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.2.3 Sanofi Pasteur Anti-Infective Vaccines Product Introduction

7.2.4 Sanofi Pasteur Response to COVID-19 and Related Developments

7.3 Merck & Co.

7.3.1 Merck & Co. Business Overview

7.3.2 Merck & Co. Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.3.3 Merck & Co. Anti-Infective Vaccines Product Introduction

7.3.4 Merck & Co. Response to COVID-19 and Related Developments

7.4 MedImmune LLC

7.4.1 MedImmune LLC Business Overview

7.4.2 MedImmune LLC Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.4.3 MedImmune LLC Anti-Infective Vaccines Product Introduction

7.4.4 MedImmune LLC Response to COVID-19 and Related Developments

7.5 Novartis Vaccines

7.5.1 Novartis Vaccines Business Overview

7.5.2 Novartis Vaccines Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.5.3 Novartis Vaccines Anti-Infective Vaccines Product Introduction

7.5.4 Novartis Vaccines Response to COVID-19 and Related Developments

7.6 Diagnostics Ltd.

7.6.1 Diagnostics Ltd. Business Overview

7.6.2 Diagnostics Ltd. Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.6.3 Diagnostics Ltd. Anti-Infective Vaccines Product Introduction

7.6.4 Diagnostics Ltd. Response to COVID-19 and Related Developments

7.7 Intercell Biomedical

7.7.1 Intercell Biomedical Business Overview

7.7.2 Intercell Biomedical Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.7.3 Intercell Biomedical Anti-Infective Vaccines Product Introduction

7.7.4 Intercell Biomedical Response to COVID-19 and Related Developments

7.8 MassBiologics

7.8.1 MassBiologics Business Overview

7.8.2 MassBiologics Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.8.3 MassBiologics Anti-Infective Vaccines Product Introduction

7.8.4 MassBiologics Response to COVID-19 and Related Developments

7.9 Barr Labs, Inc.

7.9.1 Barr Labs, Inc. Business Overview

7.9.2 Barr Labs, Inc. Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.9.3 Barr Labs, Inc. Anti-Infective Vaccines Product Introduction

7.9.4 Barr Labs, Inc. Response to COVID-19 and Related Developments

7.10 Organon Teknika Co.

7.10.1 Organon Teknika Co. Business Overview

7.10.2 Organon Teknika Co. Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.10.3 Organon Teknika Co. Anti-Infective Vaccines Product Introduction

7.10.4 Organon Teknika Co. Response to COVID-19 and Related Developments

7.11 GlaxoSmithKline Biologicals

7.11.1 GlaxoSmithKline Biologicals Business Overview

7.11.2 GlaxoSmithKline Biologicals Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Introduction

7.11.4 GlaxoSmithKline Biologicals Response to COVID-19 and Related Developments

7.12 CSL Ltd.

7.12.1 CSL Ltd. Business Overview

7.12.2 CSL Ltd. Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.12.3 CSL Ltd. Anti-Infective Vaccines Product Introduction

7.12.4 CSL Ltd. Response to COVID-19 and Related Developments

7.13 ID Biomedical Co.

7.13.1 ID Biomedical Co. Business Overview

7.13.2 ID Biomedical Co. Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.13.3 ID Biomedical Co. Anti-Infective Vaccines Product Introduction

7.13.4 ID Biomedical Co. Response to COVID-19 and Related Developments

7.14 Protein Sciences Co.

7.14.1 Protein Sciences Co. Business Overview

7.14.2 Protein Sciences Co. Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.14.3 Protein Sciences Co. Anti-Infective Vaccines Product Introduction

7.14.4 Protein Sciences Co. Response to COVID-19 and Related Developments

7.15 Wyeth Pharmaceuticals, Inc.

7.15.1 Wyeth Pharmaceuticals, Inc. Business Overview

7.15.2 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Introduction

7.15.4 Wyeth Pharmaceuticals, Inc. Response to COVID-19 and Related Developments

7.16 Berna Biotech

7.16.1 Berna Biotech Business Overview

7.16.2 Berna Biotech Anti-Infective Vaccines Quarterly Production and Revenue, 2020

7.16.3 Berna Biotech Anti-Infective Vaccines Product Introduction

7.16.4 Berna Biotech Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Anti-Infective Vaccines Supply Chain Analysis

8.1.1 Anti-Infective Vaccines Supply Chain Analysis

8.1.2 Covid-19 Impact on Anti-Infective Vaccines Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Anti-Infective Vaccines Distribution Channels

8.2.2 Covid-19 Impact on Anti-Infective Vaccines Distribution Channels

8.2.3 Anti-Infective Vaccines Distributors

8.3 Anti-Infective Vaccines Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Anti-Infective Vaccines Assessment

Table 9. COVID-19 Impact: Anti-Infective Vaccines Market Trends

Table 10. COVID-19 Impact Global Anti-Infective Vaccines Market Size

Table 11. Global Anti-Infective Vaccines Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Anti-Infective Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Anti-Infective Vaccines Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Anti-Infective Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Anti-Infective Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Anti-Infective Vaccines Market Growth Drivers

Table 17. Global Anti-Infective Vaccines Market Restraints

Table 18. Global Anti-Infective Vaccines Market Opportunities

Table 19. Global Anti-Infective Vaccines Market Challenges

Table 20. Key Manufacturers Anti-Infective Vaccines Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Anti-Infective Vaccines Market Size, 2019 (K Units) & (US$ Million)

Table 22. Anti-Infective Vaccines Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Anti-Infective Vaccines Manufacturing Plants

Table 24. Key Manufacturers Anti-Infective Vaccines Market Served

Table 25. Date of Key Manufacturers Enter into Anti-Infective Vaccines Market

Table 26. Key Manufacturers Anti-Infective Vaccines Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Anti-Infective Vaccines Market Size by Type, 2020, (US$ Million)

Table 29. Global Anti-Infective Vaccines Market Size by Type, 2020 (K Units)

Table 30. Global Anti-Infective Vaccines Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Anti-Infective Vaccines Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Anti-Infective Vaccines Market Size by Application, 2020-2021 (K Units)

Table 33. Global Anti-Infective Vaccines Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Anti-Infective Vaccines Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Anti-Infective Vaccines Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Anti-Infective Vaccines Market Size, 2019-2021 (K Units)

Table 38. US Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Anti-Infective Vaccines Market Size, 2019-2021 (K Units)

Table 43. Germany Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Anti-Infective Vaccines Market Size, 2019-2021 (K Units)

Table 50. China Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Anti-Infective Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. Emergent BioDefense Operations Lansing Inc. Business Overview

Table 58. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product

Table 60. Emergent BioDefense Operations Lansing Inc. Response to COVID-19 and Related Developments

Table 61. Sanofi Pasteur Business Overview

Table 62. Sanofi Pasteur Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Sanofi Pasteur Anti-Infective Vaccines Product

Table 64. Sanofi Pasteur Response to COVID-19 and Related Developments

Table 65. Merck & Co. Business Overview

Table 66. Merck & Co. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Merck & Co. Anti-Infective Vaccines Product

Table 68. Merck & Co. Response to COVID-19 and Related Developments

Table 69. MedImmune LLC Business Overview

Table 70. MedImmune LLC Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. MedImmune LLC Anti-Infective Vaccines Product

Table 72. MedImmune LLC Response to COVID-19 and Related Developments

Table 73. Novartis Vaccines Business Overview

Table 74. Novartis Vaccines Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Novartis Vaccines Anti-Infective Vaccines Product

Table 76. Novartis Vaccines Response to COVID-19 and Related Developments

Table 77. Diagnostics Ltd. Business Overview

Table 78. Diagnostics Ltd. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Diagnostics Ltd. Anti-Infective Vaccines Product

Table 80. Diagnostics Ltd. Response to COVID-19 and Related Developments

Table 81. Intercell Biomedical Business Overview

Table 82. Intercell Biomedical Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Intercell Biomedical Anti-Infective Vaccines Product

Table 84. Intercell Biomedical Response to COVID-19 and Related Developments

Table 85. MassBiologics Business Overview

Table 86. MassBiologics Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. MassBiologics Anti-Infective Vaccines Product

Table 88. MassBiologics Response to COVID-19 and Related Developments

Table 89. Barr Labs, Inc. Business Overview

Table 90. Barr Labs, Inc. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Barr Labs, Inc. Anti-Infective Vaccines Product

Table 92. Barr Labs, Inc. Response to COVID-19 and Related Developments

Table 93. Organon Teknika Co. Business Overview

Table 94. Organon Teknika Co. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Organon Teknika Co. Anti-Infective Vaccines Product

Table 96. Organon Teknika Co. Response to COVID-19 and Related Developments

Table 97. GlaxoSmithKline Biologicals Business Overview

Table 98. GlaxoSmithKline Biologicals Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product

Table 100. GlaxoSmithKline Biologicals Response to COVID-19 and Related Developments

Table 101. CSL Ltd. Business Overview

Table 102. CSL Ltd. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. CSL Ltd. Anti-Infective Vaccines Product

Table 104. CSL Ltd. Response to COVID-19 and Related Developments

Table 105. ID Biomedical Co. Business Overview

Table 106. ID Biomedical Co. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. ID Biomedical Co. Anti-Infective Vaccines Product

Table 108. ID Biomedical Co. Response to COVID-19 and Related Developments

Table 109. Protein Sciences Co. Business Overview

Table 110. Protein Sciences Co. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 111. Protein Sciences Co. Anti-Infective Vaccines Product

Table 112. Protein Sciences Co. Response to COVID-19 and Related Developments

Table 113. Wyeth Pharmaceuticals, Inc. Business Overview

Table 114. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 115. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product

Table 116. Wyeth Pharmaceuticals, Inc. Response to COVID-19 and Related Developments

Table 117. Berna Biotech Business Overview

Table 118. Berna Biotech Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 119. Berna Biotech Anti-Infective Vaccines Product

Table 120. Berna Biotech Response to COVID-19 and Related Developments

Table 121. Anti-Infective Vaccines Distributors List

Table 122. Anti-Infective Vaccines Customers List

Table 123. Covid-19 Impact on Anti-Infective Vaccines Customers

List of Figures

Figure 1. Anti-Infective Vaccines Product Picture

Figure 2. Anti-Infective Vaccines Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Anti-Infective Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Anti-Infective Vaccines Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Anti-Infective Vaccines Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Anti-Infective Vaccines Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Anti-Infective Vaccines Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Anti-Infective Vaccines Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Anti-Infective Vaccines Market Size Market Share, 2019-2021